Renal Allograft Function and the Tacrolimus C/D Ratio: Insights from a Prospective Study on MeltDose Tacrolimus.

J Clin Med · 2024 · PMC11508752 · PMID 39458191

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

an overall trendno p-value reported

Consistent with this result, a comparison of the C/D ratio distribution in our cohort with the literature data on IR-Tac from Thölking’s pivotal study [ 3 ] revealed that the mean C/D ratio for MeltDose tacrolimus was significantly greater than that of IR-Tac, and this indicated an overall trend toward slower metabolism.

also in 4,871 other papers

an increasing trendno p-value reported

Renal Function Outcomes The cohort exhibited stable eGFR levels in the first 3 months, followed by an increasing trend until month 12.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.